132 related articles for article (PubMed ID: 8499958)
1. Clinical experience with Systen, a new transdermal form of hormone replacement therapy.
Corson SL
Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():36-44. PubMed ID: 8499958
[TBL] [Abstract][Full Text] [Related]
2. A comparative multicenter study of two transdermal estradiol replacement therapies in the treatment of postmenopausal symptoms.
Van Leusden HA; Albertyn G; Verlaine C; Van Ruymbeke J
Int J Fertil Menopausal Stud; 1993; 38(4):210-8. PubMed ID: 8401679
[TBL] [Abstract][Full Text] [Related]
3. A randomized study to compare the effectiveness, tolerability, and acceptability of two different transdermal estradiol replacement therapies. The Transdermal HRT Investigators Group.
Int J Fertil Menopausal Stud; 1993; 38(1):5-11. PubMed ID: 8485612
[TBL] [Abstract][Full Text] [Related]
4. [An efficacy and tolerance study of transdermal estrogen replacement therapy with the preparation Systen R50 (Cilag)].
Tanchev S; Moskova P
Akush Ginekol (Sofiia); 1995; 34(2):65-7. PubMed ID: 8651434
[TBL] [Abstract][Full Text] [Related]
5. A decade of experience with transdermal estrogen replacement therapy: overview of key pharmacologic and clinical findings.
Corson SL
Int J Fertil; 1993; 38(2):79-91. PubMed ID: 8097503
[TBL] [Abstract][Full Text] [Related]
6. A randomised study to compare the efficacy and safety of new 17 beta-oestradiol transdermal matrix patch with Estraderm TTS 50 in hysterectomised postmenopausal women. The Lyrelle Study Group.
al-Azzawi F; Van der Mooren MJ; Rolland R; Hirvonen E
Br J Clin Pract; 1997; 51(1):20-3, 25-6. PubMed ID: 9158267
[TBL] [Abstract][Full Text] [Related]
7. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
Henzl MR; Loomba PK
J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
[TBL] [Abstract][Full Text] [Related]
8. Estrogen replacement therapy and the estraderm transdermal system.
Youngkin EQ
Nurse Pract; 1990 May; 15(5):19-26, 31. PubMed ID: 2342664
[TBL] [Abstract][Full Text] [Related]
9. [Hormone replacement therapy with a transdermal estradiol gel and oral micronized progesterone. Effect on menopausal symptoms and lipid metabolism].
Giuliani A; Concin H; Wieser F; Boritsch J; Wilfert H; Gruber D; Urdl W
Wien Klin Wochenschr; 2000 Jul; 112(14):629-33. PubMed ID: 11008325
[TBL] [Abstract][Full Text] [Related]
10. OESCLIM: an advanced delivery system for HRT.
Munoz A
Maturitas; 1999 Nov; 33 Suppl 1():S39-47. PubMed ID: 10661614
[TBL] [Abstract][Full Text] [Related]
11. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women.
Cacciatore B; Paakkari I; Hasselblatt R; Nieminen MS; Toivonen J; Tikkanen MI; Ylikorkala O
Am J Obstet Gynecol; 2001 Apr; 184(5):904-9. PubMed ID: 11303197
[TBL] [Abstract][Full Text] [Related]
12. [Systen--transdermal estradiol for substitution following surgical menopause].
Rachev E; Karag'ozov I
Akush Ginekol (Sofiia); 1995; 34(3):74-6. PubMed ID: 8743861
[TBL] [Abstract][Full Text] [Related]
13. New trends in transdermal technologies: development of the skin patch, Menorest.
Marty JP
Int J Gynaecol Obstet; 1996 Mar; 52 Suppl 1():S17-20. PubMed ID: 8666122
[TBL] [Abstract][Full Text] [Related]
14. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
15. Allergic contact dermatitis from transdermal estradiol and systemic contact dermatitis from oral estradiol. A case report.
Corazza M; Mantovani L; Montanari A; Virgili A
J Reprod Med; 2002 Jun; 47(6):507-9. PubMed ID: 12092023
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety and acceptability of a seven-day, transdermal estradiol patch for estrogen replacement therapy.
Jarupanich T; Lamlertkittikul S; Chandeying V
J Med Assoc Thai; 2003 Sep; 86(9):836-45. PubMed ID: 14649968
[TBL] [Abstract][Full Text] [Related]
17. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
Rozenberg S; Ylikorkala O; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with a 7-day estrogen patch: principles and practice.
Notelovitz M
Gynecol Endocrinol; 1998 Aug; 12(4):248-58. PubMed ID: 9798134
[TBL] [Abstract][Full Text] [Related]
19. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
Ettinger B; Pressman A
Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
[TBL] [Abstract][Full Text] [Related]
20. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
Araújo DA; Farias ML; Andrade AT
Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
